MEDSIR appoints Gema Llorente CFO
MEDSIR nombra a Gema Llorente directora financiera
Intel ID : 359226
|
||||
| Intel ID | 359226 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - MEDSIR
(31 Dec 2023) |
Revenue: EUR 9,80m Net Debt: EUR 13,59m People: 95 |
|
| Date |
 |
|
| Country |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.03.06 Healthcare Research & Epidemiology (Primary) 30 Healthcare / 30.03 Healthcare Facilities & Services |
|
| Secondary Subsectors (TTRSC) |
30.05.11 Oncology 30 Healthcare / 30.05 Specialized Medicine |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.06 Healthcare Research & Epidemiology 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Secondary Sectors (TTRSC) |
30.05.11 Oncology 30 Healthcare / 30.05 Specialized Medicine |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.